Viewing nowCombinationTwin Terra Tablet 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
JW Pharmaceutical Co., Ltd.

MFDS item code 201605838 · Approved 2016.09.30
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan. Essential hypertension is a condition characterized by persistently high blood pressure, which increases the risk of various complications. This medication contains two active ingredients that work effectively to lower and stabilize blood pressure. Thus, it plays a significant role in the health management of patients who find it difficult to control their blood pressure. By taking this medication, patients can improve their blood pressure control and reduce the risk of complications. It is used for the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients who should be administered this medicine with caution’.) In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, therefore it should be discontinued immediately if pregnancy is confirmed. This medication is contraindicated for patients with certain conditions or situations, so be sure to consult a doctor. Patients with impaired liver or kidney function need special attention while using this medication, and their status should be frequently checked through blood tests. During treatment, side effects such as dizziness or swelling may occur, so any unusual symptoms should be reported to medical personnel immediately. There is a possibility of blood pressure dropping too low, so if symptoms of hypotension appear, the patient should be laid down and, if necessary, receive appropriate treatment at a hospital. This medication can interact with other drugs, so if you are taking other medications, you must inform your healthcare provider. It is advisable for breastfeeding women not to take this medication, and pregnant women should choose another safe treatment option instead. Elderly patients may be more sensitive to this medication, so dosage adjustments and careful observation are necessary. In case of overdose, symptoms such as hypotension, dizziness, or heart issues may occur, so immediate treatment should be sought at a medical institution. This medication is not recommended for children, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, it is important to maintain a temperature between 1°C and 30°C when storing the medication. By doing so, the efficacy and safety of the medication can be well preserved.
A two-sided, convex, oval-shaped double tablet with white and light gray.
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.